StoxSyngene International vs Rainbow Childrens Medicare: share price & financials comparison
NSE: SYNGENE vs RAINBOW · Healthcare · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Syngene International vs Rainbow Childrens Medicare at a glance
Syngene International (SYNGENE) has a market capitalisation of ₹17,936 Cr, against ₹12,914 Cr for Rainbow Childrens Medicare (RAINBOW). Over the past year Rainbow Childrens Medicare has returned -8.6%, compared with -31.3% for Syngene International. On valuation, Rainbow Childrens Medicare trades at a lower P/E of 44.2 versus 469.5. Rainbow Childrens Medicare earns a higher return on equity (17.0% vs 0.8%). Syngene International comes out ahead on valuation and technicals. Rainbow Childrens Medicare comes out ahead on size, profitability, growth and momentum. Across the scored metrics below, Syngene International leads on 4 and Rainbow Childrens Medicare on 10. On StoxGud's 10-point checklist, Syngene International scores 3/10 and Rainbow Childrens Medicare scores 5/10.
| Metric | Syngene International | Rainbow Childrens Medicare |
|---|---|---|
| Size | ||
| Market cap | ₹17,936 Cr | ₹12,914 Cr |
| Revenue (latest FY) | ₹3,739 Cr | ₹1,703 Cr |
| Net profit (latest FY) | ₹0 Cr | ₹278 Cr |
| Valuation | ||
| P/E | 469.5 | 44.2 |
| P/B | 3.69 | 7.53 |
| Dividend yield | 0.28% | 0.24% |
| Profitability | ||
| Return on equity | 0.8% | 17.0% |
| Net profit margin | 1.1% | 15.2% |
| Operating margin | 21.3% | 31.0% |
| Growth | ||
| Revenue growth (YoY) | -8.6% | +23.2% |
| Net profit growth (YoY) | — | +9.1% |
| Revenue CAGR (multi-year) | +11.3% | +15.0% |
| Financial health | ||
| Debt to equity | 0.01 | 0.00 |
| Momentum | ||
| 1-month return | +17.1% | +4.5% |
| 1-year return | -31.3% | -8.6% |
| 3-year CAGR | -14.4% | +7.7% |
| 5-year CAGR | -5.6% | — |
| 10-year CAGR | +5.1% | — |
| Distance from 52W high | -33.1% | -20.5% |
| Technicals | ||
| RSI (14) | 77 | 71 |
| Price vs 200-day avg | +5.4% | -3.8% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Syngene International | Rainbow Childrens Medicare |
|---|---|---|
| Price above 50-day average | ✓ | ✗ |
| Price above 200-day average | ✓ | ✗ |
| 50-day average above 200-day (uptrend) | ✗ | ✗ |
| RSI in healthy 40–70 zone | ✗ | ✗ |
| Positive 1-year return | ✗ | ✗ |
| Return on equity above 15% | ✗ | ✓ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✗ | ✓ |
| Net profit margin above 10% | ✗ | ✓ |
| P/E below industry median | ✗ | ✓ |
| Score | 3/10 | 5/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Syngene International or Rainbow Childrens Medicare?
Syngene International has a market cap of ₹17,936 Cr and Rainbow Childrens Medicare has a market cap of ₹12,914 Cr as of 13 Nov 2026.
Which has a lower P/E, Syngene International or Rainbow Childrens Medicare?
Rainbow Childrens Medicare has the lower P/E: Syngene International trades at 469.5 and Rainbow Childrens Medicare at 44.2.
Which gave better returns in the last year, Syngene International or Rainbow Childrens Medicare?
Rainbow Childrens Medicare did better: Syngene International returned -31.3% and Rainbow Childrens Medicare returned -8.6% over one year.
What is the difference between Syngene International and Rainbow Childrens Medicare?
Both are NSE-listed companies in Healthcare. Syngene International is about 1.4 times the size of Rainbow Childrens Medicare by market cap. In the latest financial year Syngene International reported revenue of ₹3,739 Cr and Rainbow Childrens Medicare ₹1,703 Cr. Operating margin is 21.3% for Syngene International and 31.0% for Rainbow Childrens Medicare. Debt to equity is 0.01 for Syngene International and 0.00 for Rainbow Childrens Medicare.
Which is better, Syngene International or Rainbow Childrens Medicare?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Syngene International leads on 4 and Rainbow Childrens Medicare on 10. Syngene International is ahead on valuation and technicals. Rainbow Childrens Medicare is ahead on size, profitability, growth and momentum. On StoxGud's rules-based checklist Syngene International scores 3/10 and Rainbow Childrens Medicare scores 5/10. This is information, not advice: consult a SEBI-registered adviser before investing.